Cargando…

Editorial: Murine Models of Leukemia and Lymphoma

Detalles Bibliográficos
Autores principales:	Cutucache, Christine E., Porcu, Pierluigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770651/ https://www.ncbi.nlm.nih.gov/pubmed/29376024 http://dx.doi.org/10.3389/fonc.2017.00309

Ejemplares similares

Overview of the Use of Murine Models in Leukemia and Lymphoma Research
por: Kohnken, Rebecca, et al.
Publicado: (2017)

Using Murine Models to Investigate Tumor–Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma
por: Herek, Tyler A., et al.
Publicado: (2017)

Murine Models of Splenic Marginal Zone Lymphoma: A Role for Cav1?
por: Patten, Chelsey L., et al.
Publicado: (2016)

Burrowing through the Heterogeneity: Review of Mouse Models of PTCL-NOS
por: Cutucache, Christine E., et al.
Publicado: (2016)

Targeting the Bcl-2 Family in B Cell Lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Identification of a Splenic Marginal Zone Lymphoma Signature: Preliminary Findings With Diagnostic Potential
por: Robinson, Jacob E., et al.
Publicado: (2020)

Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL)
por: Sokol, Kelsey, et al.
Publicado: (2019)

Murine Models of Acute Myeloid Leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2022)

Corrigendum: Murine models of acute myeloid leukemia
por: Kurtz, Kristen J., et al.
Publicado: (2023)

Cytokines in the Pathogenesis of Large Granular Lymphocytic Leukemia
por: Isabelle, Colleen, et al.
Publicado: (2022)

Point and counterpoint: Polatuzumab vedotin in the front-line therapy for diffuse large B- cell lymphoma
por: Thomas, Colin, et al.
Publicado: (2023)

Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities
por: Rosenberg, Maya, et al.
Publicado: (2023)

Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
por: Jacoby, Elad, et al.
Publicado: (2014)

Incidence, Treatment, and Survival of Patients With T-Cell Lymphoma, T-Cell Large Granular Leukemia, and Concomitant Plasma Cell Dyscrasias
por: Braunstein, Zachary, et al.
Publicado: (2022)

Editorial: Cellular and Molecular Mechanisms of Immune Checkpoint Blockers in Anti-leukemia/Lymphoma Immune Therapy
por: Ganjalikhani-Hakemi, Mazdak, et al.
Publicado: (2022)

Editorial: HBV and lymphoma
por: Gentile, Giuseppe, et al.
Publicado: (2023)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

The Genetic and Molecular Basis for Canine Models of Human Leukemia and Lymphoma
por: Avery, Anne C.
Publicado: (2020)

Editorial: Metabolic Rewiring in Leukemias
por: Noguera, Nelida I., et al.
Publicado: (2021)

The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma
por: Tyler, Kelly H., et al.
Publicado: (2015)

Deciphering splenic marginal zone lymphoma pathogenesis: the proposed role of microRNA
por: Robinson, Jacob E., et al.
Publicado: (2018)

Editorial: Cutaneous B-Cell Lymphomas
por: Alaibac, Mauro, et al.
Publicado: (2020)

Editorial: Advances in the treatment of Hodgkin lymphoma
por: Mei, Matthew, et al.
Publicado: (2023)

Treating Cutaneous T-Cell Lymphoma with Highly Irregular Surfaces with Photon Irradiation Using Rice as Tissue Compensator
por: Majithia, Lonika, et al.
Publicado: (2015)

Editorial: Microenvironment and therapy-resistance in leukemias
por: Friedmann, Rachel, et al.
Publicado: (2023)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Editorial: Advances in the treatment of chronic myeloid leukemia
por: Eşkazan, Ahmet Emre, et al.
Publicado: (2023)

Editorial: Precision medicine for acute myeloid leukemia
por: Marconi, Giovanni, et al.
Publicado: (2023)

Editorial: Acute leukemias: molecular characterization, leukemia-initiating cells, and influence of the microenvironment
por: Dancik, Garrett M., et al.
Publicado: (2023)

Generation of a Murine Model for c-MYC and BCL2 Co-expression B Cell Lymphomas
por: Cai, Zhenming, et al.
Publicado: (2020)

Editorial: Pathogenesis, treatment, and future directions for rare T-cell leukemias
por: Herling, Marco, et al.
Publicado: (2022)

Editorial: Real World Outcomes of Lymphoma From India
por: Kumar, Lalit, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 Vaccination in Patients With Lymphoproliferative Disorders and Plasma Cell Dyscrasias: Anti-Lymphoma Therapy as a Predictive Biomarker of Response to Vaccination
por: Gung, Carol, et al.
Publicado: (2022)

Editorial: NK/T-Cell Lymphoma: Biology, Prognostics, Prediction, and Treatment
por: El Cheikh, Jean, et al.
Publicado: (2022)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

Editorial: Genetic/epigenetic mechanisms and related clinical strategy in leukemia
por: Li, Yonghui, et al.
Publicado: (2023)

Editorial: Understanding leukemia biology using genome editing techniques
por: Jimenez-Morales, Silvia, et al.
Publicado: (2023)

Editorial: Implementation of novel drugs and modern radiotherapy in the treatment of lymphoma patients
por: Levis, Mario, et al.
Publicado: (2023)

Treating Early-Stage DLBCL on the FLYER: What Lesson for Radiation Therapy?
por: Sokol, Kelsey, et al.
Publicado: (2021)

Editorial: Acute myeloid leukemia (AML): Is it time for MRD-driven treatment?
por: Guolo, Fabio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qi91c8pmam246n6hjstp2qlmnv